Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Ensysce Biosciences, Inc.

ENSC · Nasdaq · CIK 0001716947 · Healthcare · Biotechnology

INSIDER SIGNAL

54.0 / 100

1 buyers · 2 purchase transaction lines · $444.1K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeModerate
RoleStrong
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+14.0 / 25
Role+20.0 / 20
Recency+3.0 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase activity is becoming less recent
  • ✓ Role scores high · most senior buyer: Director

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
GOWER BOB GDirector
●●
● Purchase▼ Sale○ Other

—

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: GOWER BOB G · $444.1K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-04-23–2026-04-23

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

54.0 / 100

Latest recorded score

↓ -0.2 ptsversus the previous recorded snapshot
  1. 54.5
  2. 54.3
  3. 54.3
  4. 54.2
  5. 54.0

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

2Purchases
0Sales
0Other Form 4 lines
1SEC filings · 365 days
BUYING2 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+2.1%
3M
+90.9%
6M
+13.3%
12M
-78.6%

Volatility & liquidity

Volatility
187.0%
Beta
—
Avg daily value
USD 7.6M

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
-200.8%
ROE
-316.6%
Industry
Biotechnology

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
1,080,946
Previous report
1,205,824
Avg daily volume
322,664
Days to cover
3.4

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-07GOWER BOB GPurchase (P)Common Stock400,000USD 0.50USD 200,000SEC filing ↗
2026-04-23GOWER BOB GPurchase (P)Common Stock508,614USD 0.48USD 244,135SEC filing ↗
2023-03-02GOWER BOB GPurchase (P)Common Stock90,287USD 0.49USD 44,241SEC filing ↗
2023-03-01GOWER BOB GPurchase (P)Common Stock270,000USD 0.48USD 129,600SEC filing ↗
2023-02-28GOWER BOB GPurchase (P)Common Stock109,300USD 0.49USD 53,557SEC filing ↗
2022-12-09GOWER BOB GPurchase (P)Common Stock357,143USD 1.40USD 500,000SEC filing ↗
2022-05-26Kirkpatrick LynnPurchase (P)Common Stock27,000USD 0.53USD 14,310SEC filing ↗
2022-05-25Kirkpatrick LynnPurchase (P)Common Stock70,000USD 0.49USD 34,300SEC filing ↗

Form 4 evidence

2 transaction lines in the latest 365-day window; 14 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-07GOWER BOB GPurchase (P)Common Stock400,000USD 0.50USD 200,000SEC filing ↗
2026-04-23GOWER BOB GPurchase (P)Common Stock508,614USD 0.48USD 244,135SEC filing ↗
Show recent Form 4 evidence (2 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-07GOWER BOB GPurchase (P)Common Stock400,000USD 0.50USD 200,000SEC filing ↗
2026-04-23GOWER BOB GPurchase (P)Common Stock508,614USD 0.48USD 244,135SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerENSC
CIK0001716947
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history14 transaction lines from 2020-06-19 to 2026-08-07
8 P purchase lines · 1 S sale lines · 5 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.